Click for best price
Cancer Medication Market Size, Share 2023
The global Cancer Medication market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Cancer Medication market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Cancer Medication market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Cancer Medication market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Cancer Medication are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
This report aims to provide a comprehensive presentation of the global market for Cancer Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Medication. This report contains market size and forecasts of Cancer Medication in global, including the following market information:
- Global Cancer Medication Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antimetabolite Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Medication include Roche, HENGRUI, AstraZeneca, QILU, Sanofi, HANSOH, LUYE, Novartis and GuiZhou YiBai, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Medication Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cancer Medication Market Segment Percentages, by Type, 2022 (%)
- Antimetabolite
- Alkaloid Drugs
- Hormone
- Targeted Drug
- Platinum-based Drugs
- Other
Global Cancer Medication Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cancer Medication Market Segment Percentages, by Application, 2022 (%)
- Blood Cancer
- Breast Cancer
- Castrointestinal Cancer
- Prostate Cancer
- Respiratory/Lung Cancer
- Other
Global Cancer Medication Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cancer Medication Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cancer Medication revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Cancer Medication revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- HENGRUI
- AstraZeneca
- QILU
- Sanofi
- HANSOH
- LUYE
- Novartis
- GuiZhou YiBai
- Lunan
- Eli Lilly and Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Medication, market overview.
Chapter 2: Global Cancer Medication market size in revenue.
Chapter 3: Detailed analysis of Cancer Medication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Medication Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Medication Overall Market Size
2.1 Global Cancer Medication Market Size: 2022 VS 2030
2.2 Global Cancer Medication Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Medication Players in Global Market
3.2 Top Global Cancer Medication Companies Ranked by Revenue
3.3 Global Cancer Medication Revenue by Companies
3.4 Top 3 and Top 5 Cancer Medication Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Medication Players in Global Market
3.6.1 List of Global Tier 1 Cancer Medication Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Medication Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Medication Market Size Markets, 2022 & 2030
4.1.2 Antimetabolite
4.1.3 Alkaloid Drugs
4.1.4 Hormone
4.1.5 Targeted Drug
4.1.6 Platinum-based Drugs
4.1.7 Other
4.2 By Type - Global Cancer Medication Revenue & Forecasts
4.2.1 By Type - Global Cancer Medication Revenue, 2018-2023
4.2.2 By Type - Global Cancer Medication Revenue, 2024-2030
4.2.3 By Type - Global Cancer Medication Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Medication Market Size, 2022 & 2030
5.1.2 Blood Cancer
5.1.3 Breast Cancer
5.1.4 Castrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Respiratory/Lung Cancer
5.1.7 Other
5.2 By Application - Global Cancer Medication Revenue & Forecasts
5.2.1 By Application - Global Cancer Medication Revenue, 2018-2023
5.2.2 By Application - Global Cancer Medication Revenue, 2024-2030
5.2.3 By Application - Global Cancer Medication Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cancer Medication Market Size, 2022 & 2030
6.2 By Region - Global Cancer Medication Revenue & Forecasts
6.2.1 By Region - Global Cancer Medication Revenue, 2018-2023
6.2.2 By Region - Global Cancer Medication Revenue, 2024-2030
6.2.3 By Region - Global Cancer Medication Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cancer Medication Revenue, 2018-2030
6.3.2 US Cancer Medication Market Size, 2018-2030
6.3.3 Canada Cancer Medication Market Size, 2018-2030
6.3.4 Mexico Cancer Medication Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Medication Revenue, 2018-2030
6.4.2 Germany Cancer Medication Market Size, 2018-2030
6.4.3 France Cancer Medication Market Size, 2018-2030
6.4.4 U.K. Cancer Medication Market Size, 2018-2030
6.4.5 Italy Cancer Medication Market Size, 2018-2030
6.4.6 Russia Cancer Medication Market Size, 2018-2030
6.4.7 Nordic Countries Cancer Medication Market Size, 2018-2030
6.4.8 Benelux Cancer Medication Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Medication Revenue, 2018-2030
6.5.2 China Cancer Medication Market Size, 2018-2030
6.5.3 Japan Cancer Medication Market Size, 2018-2030
6.5.4 South Korea Cancer Medication Market Size, 2018-2030
6.5.5 Southeast Asia Cancer Medication Market Size, 2018-2030
6.5.6 India Cancer Medication Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cancer Medication Revenue, 2018-2030
6.6.2 Brazil Cancer Medication Market Size, 2018-2030
6.6.3 Argentina Cancer Medication Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Medication Revenue, 2018-2030
6.7.2 Turkey Cancer Medication Market Size, 2018-2030
6.7.3 Israel Cancer Medication Market Size, 2018-2030
6.7.4 Saudi Arabia Cancer Medication Market Size, 2018-2030
6.7.5 UAE Cancer Medication Market Size, 2018-2030
7 Cancer Medication Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Cancer Medication Major Product Offerings
7.1.4 Roche Cancer Medication Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 HENGRUI
7.2.1 HENGRUI Company Summary
7.2.2 HENGRUI Business Overview
7.2.3 HENGRUI Cancer Medication Major Product Offerings
7.2.4 HENGRUI Cancer Medication Revenue in Global Market (2018-2023)
7.2.5 HENGRUI Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Cancer Medication Major Product Offerings
7.3.4 AstraZeneca Cancer Medication Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 QILU
7.4.1 QILU Company Summary
7.4.2 QILU Business Overview
7.4.3 QILU Cancer Medication Major Product Offerings
7.4.4 QILU Cancer Medication Revenue in Global Market (2018-2023)
7.4.5 QILU Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Cancer Medication Major Product Offerings
7.5.4 Sanofi Cancer Medication Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 HANSOH
7.6.1 HANSOH Company Summary
7.6.2 HANSOH Business Overview
7.6.3 HANSOH Cancer Medication Major Product Offerings
7.6.4 HANSOH Cancer Medication Revenue in Global Market (2018-2023)
7.6.5 HANSOH Key News & Latest Developments
7.7 LUYE
7.7.1 LUYE Company Summary
7.7.2 LUYE Business Overview
7.7.3 LUYE Cancer Medication Major Product Offerings
7.7.4 LUYE Cancer Medication Revenue in Global Market (2018-2023)
7.7.5 LUYE Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Cancer Medication Major Product Offerings
7.8.4 Novartis Cancer Medication Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 GuiZhou YiBai
7.9.1 GuiZhou YiBai Company Summary
7.9.2 GuiZhou YiBai Business Overview
7.9.3 GuiZhou YiBai Cancer Medication Major Product Offerings
7.9.4 GuiZhou YiBai Cancer Medication Revenue in Global Market (2018-2023)
7.9.5 GuiZhou YiBai Key News & Latest Developments
7.10 Lunan
7.10.1 Lunan Company Summary
7.10.2 Lunan Business Overview
7.10.3 Lunan Cancer Medication Major Product Offerings
7.10.4 Lunan Cancer Medication Revenue in Global Market (2018-2023)
7.10.5 Lunan Key News & Latest Developments
7.11 Eli Lilly and Company
7.11.1 Eli Lilly and Company Company Summary
7.11.2 Eli Lilly and Company Business Overview
7.11.3 Eli Lilly and Company Cancer Medication Major Product Offerings
7.11.4 Eli Lilly and Company Cancer Medication Revenue in Global Market (2018-2023)
7.11.5 Eli Lilly and Company Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Medication Market Opportunities & Trends in Global Market
Table 2. Cancer Medication Market Drivers in Global Market
Table 3. Cancer Medication Market Restraints in Global Market
Table 4. Key Players of Cancer Medication in Global Market
Table 5. Top Cancer Medication Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Medication Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Medication Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Medication Product Type
Table 9. List of Global Tier 1 Cancer Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Medication Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cancer Medication Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Medication Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cancer Medication Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cancer Medication Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Medication Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cancer Medication Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cancer Medication Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Medication Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cancer Medication Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Medication Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cancer Medication Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Medication Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cancer Medication Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Medication Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cancer Medication Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Medication Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cancer Medication Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Medication Revenue, (US$, Mn), 2024-2030
Table 30. Roche Company Summary
Table 31. Roche Cancer Medication Product Offerings
Table 32. Roche Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. HENGRUI Company Summary
Table 35. HENGRUI Cancer Medication Product Offerings
Table 36. HENGRUI Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 37. HENGRUI Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Cancer Medication Product Offerings
Table 40. AstraZeneca Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. QILU Company Summary
Table 43. QILU Cancer Medication Product Offerings
Table 44. QILU Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 45. QILU Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Cancer Medication Product Offerings
Table 48. Sanofi Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. HANSOH Company Summary
Table 51. HANSOH Cancer Medication Product Offerings
Table 52. HANSOH Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 53. HANSOH Key News & Latest Developments
Table 54. LUYE Company Summary
Table 55. LUYE Cancer Medication Product Offerings
Table 56. LUYE Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 57. LUYE Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Cancer Medication Product Offerings
Table 60. Novartis Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. GuiZhou YiBai Company Summary
Table 63. GuiZhou YiBai Cancer Medication Product Offerings
Table 64. GuiZhou YiBai Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 65. GuiZhou YiBai Key News & Latest Developments
Table 66. Lunan Company Summary
Table 67. Lunan Cancer Medication Product Offerings
Table 68. Lunan Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 69. Lunan Key News & Latest Developments
Table 70. Eli Lilly and Company Company Summary
Table 71. Eli Lilly and Company Cancer Medication Product Offerings
Table 72. Eli Lilly and Company Cancer Medication Revenue (US$, Mn) & (2018-2023)
Table 73. Eli Lilly and Company Key News & Latest Developments
List of Figures
Figure 1. Cancer Medication Segment by Type in 2022
Figure 2. Cancer Medication Segment by Application in 2022
Figure 3. Global Cancer Medication Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Medication Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cancer Medication Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Medication Revenue in 2022
Figure 8. By Type - Global Cancer Medication Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cancer Medication Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cancer Medication Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cancer Medication Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cancer Medication Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cancer Medication Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cancer Medication Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cancer Medication Revenue Market Share, 2018-2030
Figure 16. US Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cancer Medication Revenue Market Share, 2018-2030
Figure 20. Germany Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 21. France Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cancer Medication Revenue Market Share, 2018-2030
Figure 28. China Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 32. India Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cancer Medication Revenue Market Share, 2018-2030
Figure 34. Brazil Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cancer Medication Revenue Market Share, 2018-2030
Figure 37. Turkey Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cancer Medication Revenue, (US$, Mn), 2018-2030
Figure 41. Roche Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. HENGRUI Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. QILU Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. HANSOH Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. LUYE Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GuiZhou YiBai Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Lunan Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Eli Lilly and Company Cancer Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
